Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Labcorp Holdings Inc. LH

Healthcare  —  Diagnostics & Research
309.64 0.69 0.22% as of 25 Sep
Market cap
$21.9B
P/E
25.4×
S&P 500 Member Dividend Champion (5y) Revenue Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Labcorp Holdings Inc. (LH) Price to free cash flow

As of 25 September 2026, Labcorp Holdings Inc. (LH) trades at a price to free cash flow of 24.5×. Over the past ten years it has ranged from 7.7× (April 2021) to 34.3× (April 2024); the current reading is higher than 89% of that period. That is below the Diagnostics & Research industry median of 34.0× and above the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 19.4× (3.22%)
FY2024 20.0× (27.11%)
FY2023 27.5× 125.45%
FY2022 12.2× 29.59%
FY2021 9.4× (0.79%)
FY2020 9.5× (30.00%)
FY2019 13.6× 19.84%
FY2018 11.3× (5.87%)
FY2017 12.0× 0.34%
FY2016 12.0× (17.01%)

Quarterly

Period Price to free cash flow Change
Jun 2026 22.2× 27.27%
Mar 2026 17.4× (10.26%)
Dec 2025 19.4× 1.47%
Sep 2025 19.1× (1.50%)
42 more quarters

Against its own ten years

Low 7.7× High 34.3×
Ten-year median 13.7×
Current reading's percentile 89

Price to free cash flow against peers

Company Price to free cash flow
GH Guardant Health, Inc. compare n/m
TWST Twist Bioscience Corporation compare n/m
ICLR ICON PLC compare 15.0×
DGX Quest Diagnostics Incorporated compare 19.4×
LH Labcorp Holdings Inc. 24.5×
MEDP Medpace Holdings, Inc. compare 24.7×
RVTY Revvity Inc. compare 29.8×
MTD Mettler-Toledo International, Inc. compare 35.2×
CRL Charles River Laboratories International, Inc. compare 37.9×
Diagnostics & Research industry median 34.0×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on LH